187 related articles for article (PubMed ID: 36494837)
21. Scoring system based on tumor markers and Child-Pugh classification for HCC patients who underwent liver resection.
Nakagawa S; Hayashi H; Nitta H; Okabe H; Sakamoto K; Higashi T; Kuroki H; Imai K; Hashimoto D; Sakamoto Y; Chikamoto A; Beppu T; Baba H
Anticancer Res; 2015 Apr; 35(4):2157-63. PubMed ID: 25862872
[TBL] [Abstract][Full Text] [Related]
22. Multi-institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinoma.
Wang XH; Liu QB; Xiang CL; Mao XH; Yang B; Li Q; Zhou QF; Li SQ; Zhou ZG; Chen MS
Int J Cancer; 2021 Jul; 149(1):127-138. PubMed ID: 33586134
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma.
Kamiyama T; Nakanishi K; Yokoo H; Kamachi H; Tahara M; Kakisaka T; Tsuruga Y; Todo S; Taketomi A
World J Surg Oncol; 2012 Jun; 10():107. PubMed ID: 22697061
[TBL] [Abstract][Full Text] [Related]
24. Factors predictive of survival after stapler hepatectomy of hepatocellular carcinoma: a multivariate, single-center analysis.
Hoffmann K; Müller-Bütow V; Franz C; Hinz U; Longerich T; Büchler MW; Schemmer P
Anticancer Res; 2014 Feb; 34(2):767-76. PubMed ID: 24511011
[TBL] [Abstract][Full Text] [Related]
25. Risk Factors Associated with Intraoperative Major Blood Loss during Resection of Hepatocellular Carcinoma.
Chen JS; Huang JQ; Chen XL; Zhan GF; Feng JT
Hepatogastroenterology; 2015 Jun; 62(140):790-3. PubMed ID: 26902002
[TBL] [Abstract][Full Text] [Related]
26. Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.
Zhang XF; Yin ZF; Wang K; Zhang ZQ; Qian HH; Shi LH
Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):618-23. PubMed ID: 23232633
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinoma.
Ho CM; Wu CY; Lee PH; Lai HS; Ho MC; Wu YM; Hu RH
Ann Surg Oncol; 2013 Aug; 20(8):2526-33. PubMed ID: 23504121
[TBL] [Abstract][Full Text] [Related]
28. A prognostic model and treatment strategy for intrahepatic recurrence of hepatocellular carcinoma after curative resection.
Umeda Y; Matsuda H; Sadamori H; Matsukawa H; Yagi T; Fujiwara T
World J Surg; 2011 Jan; 35(1):170-7. PubMed ID: 20922387
[TBL] [Abstract][Full Text] [Related]
29. Metavir and FIB-4 scores are associated with patient prognosis after curative hepatectomy in hepatitis B virus-related hepatocellular carcinoma: a retrospective cohort study at two centers in China.
Liao R; Fu YP; Wang T; Deng ZG; Li DW; Fan J; Zhou J; Feng GS; Qiu SJ; Du CY
Oncotarget; 2017 Jan; 8(1):1774-1787. PubMed ID: 27662665
[TBL] [Abstract][Full Text] [Related]
30. Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy: a retrospective study of 601 Chinese patients.
Zhang TT; Zhao XQ; Liu Z; Mao ZY; Bai L
Clin Transl Oncol; 2016 Aug; 18(8):831-40. PubMed ID: 26577107
[TBL] [Abstract][Full Text] [Related]
31. Prognoses, outcomes, and clinicopathological characteristics of very elderly patients with hepatocellular carcinoma who underwent hepatectomy.
Shimada S; Kamiyama T; Orimo T; Nagatsu A; Asahi Y; Sakamoto Y; Kamachi H; Taketomi A
World J Surg Oncol; 2020 Jun; 18(1):122. PubMed ID: 32522259
[TBL] [Abstract][Full Text] [Related]
32. [Impact of surgical operation-related factors on long-term survival of patients with hepatocellular carcinoma after hepatectomy].
Lü WP; Dong JH; Zhang WZ; Huang XQ; Wang SG; Bie P
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):386-92. PubMed ID: 18795607
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection.
Yamanaka J; Yamanaka N; Nakasho K; Tanaka T; Ando T; Yasui C; Kuroda N; Takata M; Maeda S; Matsushita K; Uematsu K; Okamoto E
J Gastroenterol Hepatol; 2000 Oct; 15(10):1192-8. PubMed ID: 11106101
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological features, post-surgical survival and prognostic indicators of elderly patients with hepatocellular carcinoma.
Zhou L; Rui JA; Wang SB; Chen SG; Qu Q; Chi TY; Wei X; Han K; Zhang N; Zhao HT
Eur J Surg Oncol; 2006 Sep; 32(7):767-72. PubMed ID: 16725304
[TBL] [Abstract][Full Text] [Related]
35. Is hepatectomy beneficial in the treatment of multinodular hepatocellular carcinoma?
Wang BW; Mok KT; Liu SI; Chou NH; Tsai CC; Chen IS; Yeh MH; Chen YC
J Formos Med Assoc; 2008 Aug; 107(8):616-26. PubMed ID: 18678545
[TBL] [Abstract][Full Text] [Related]
36. No impact of perioperative blood transfusion on prognosis after curative resection for hepatocellular carcinoma: a propensity score matching analysis.
Peng T; Zhao G; Wang L; Wu J; Cui H; Liang Y; Zhou R; Liu Z; Wang Q
Clin Transl Oncol; 2018 Jun; 20(6):719-728. PubMed ID: 29080121
[TBL] [Abstract][Full Text] [Related]
37. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
[TBL] [Abstract][Full Text] [Related]
38. Distinguished prognosis after hepatectomy of HBV-related hepatocellular carcinoma with or without cirrhosis: a long-term follow-up analysis.
Yang SL; Liu LP; Sun YF; Yang XR; Fan J; Ren JW; Chen GG; Lai PB
J Gastroenterol; 2016 Jul; 51(7):722-32. PubMed ID: 26607653
[TBL] [Abstract][Full Text] [Related]
39. Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients.
Tsilimigras DI; Bagante F; Moris D; Merath K; Paredes AZ; Sahara K; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
Surgery; 2019 Dec; 166(6):967-974. PubMed ID: 31606196
[TBL] [Abstract][Full Text] [Related]
40. Fucosylated fraction of alpha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment.
Tamura Y; Igarashi M; Suda T; Wakai T; Shirai Y; Umemura T; Tanaka E; Kakizaki S; Takagi H; Hiasa Y; Onji M; Aoyagi Y
Dig Dis Sci; 2010 Jul; 55(7):2095-101. PubMed ID: 19731025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
